Temozolomide 5 Mg Capsule Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets and Oral Capsules
Available Strengths: Capsules: 5 mg, 20 mg, 100 mg, 140 mg; Tablets: 250 mg
Reference Brands: Temodar® (US & EU)
Category: Oncology Cancer Care
Temozolomide (brand name Temodar®) is an oral chemotherapy used for glioblastoma multiforme (GBM) and anaplastic astrocytoma. Available in 5 mg, 20 mg, 100 mg, 140 mg, and 250 mg strengths, it is approved in both the US and EU. Manufactured under GMP standards, Temozolomide is a key oncology treatment for global B2B pharmaceutical distribution.
Product Description:
Temozolomide is an oral chemotherapy agent used in the treatment of glioblastoma multiforme (GBM) and anaplastic astrocytoma, two aggressive brain cancers. Temozolomide works by damaging cancer cell DNA, preventing replication and inducing cell death. Available in 5 mg, 20 mg, 100 mg, 140 mg, and 250 mg strengths, it is marketed under the brand name Temodar® by Merck in both the US and EU. Manufactured under GMP-compliant facilities, it offers a reliable treatment option for oncology-focused pharmaceutical partners, providing a vital oral chemotherapy solution in the global cancer treatment market.
Temozolomide 5 Mg Capsule — third party manufacturing & bulk supply
Temozolomide 5 Mg Capsule is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Temozolomide 5 Mg Capsule listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Temozolomide 5 Mg Capsule →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Temozolomide is an antineoplastic (anti-cancer) medicine used primarily for the treatment of certain brain cancers, including glioblastoma multiforme and anaplastic astrocytoma. It works by damaging the DNA of cancer cells, which inhibits their ability to multiply and causes cell death. Temozolomide is often used in combination with radiotherapy or as maintenance therapy to improve treatment outcomes.
Temozolomide is made from the active pharmaceutical ingredient temozolomide, an oral alkylating agent that belongs to the imidazotetrazine class of chemotherapeutic drugs.
The main trade name is Temodar. Other regional brand names include Temodal and Temcad.
Temodar was originally developed and marketed by Merck & Co. Generic versions are manufactured by various pharmaceutical companies worldwide.
The generic name is temozolomide.
Brand names include Temodar, Temodal, and Temcad, along with multiple regional generics.
Temozolomide is manufactured in regulated pharmaceutical facilities in the USA, EU, UK, India, and other countries depending on the manufacturer and marketing authorization holder.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
